![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Huson L. W.
Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.17, Iss.1, 2007-01, pp. : 159-172
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phase III HIV-1 vaccine trials require better rationale
Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Kebba Anthony Imami Nesrina Bugembe-Lule Daniel Senkaali David Kaleebu Pontiano Grosskurth Heiner Gotch Frances
Pharmacogenomics, Vol. 8, Iss. 4, 2007-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Missing Data Imputation in Quality-of-Life Assessment: Imputation for WHOQOL-BREF
PharmacoEconomics, Vol. 24, Iss. 9, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Missing Data in Confirmatory Clinical Trials
Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. :